Scientists are learning how to revive faltering human cells by loading them with fresh power plants, effectively repairing ...

Tariff pressures, a changing regulatory environment, and risk-averse investors have left many Cambridge biotechnology ...

There’s an emerging intersection between healthcare and technology, with the former’s evolution largely dependent on the latter. For investors who want exposure to that theme without the burden of ...